title: Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders.
abstract: Childhood-onset mood disorders (COMD) are often familial, and twin studies of COMD provide compelling evidence that genetic factors are involved. Deficits in neural plasticity have been suggested to underlie the development of depression. The receptor tropomyosin related kinase B (TrkB) and its ligand, brain derived neurotrophic factor (BDNF), play essential roles in neural plasticity, and mRNA expression of both of these genes has been shown to be influenced by stress and chronic antidepressant treatment. In addition, TrkB knock-out mice display inappropriate stress coping mechanisms. Having previously shown that BDNF is associated with COMD, in this study we investigated the gene encoding TrkB, neurotrophic tyrosine kinase, receptor, type 2 (NTRK2) as a susceptibility factor in COMD. We tested for association of NTRK2 with COMD in two independent samples: (a) a case-control sample matched on ethnicity and gender, consisting of 120 cases who met DSM III/IV criteria for major depressive or dysthymic disorder before age 14 or bipolar I/II before the age of 18, and controls, and (b) a family based control sample of 113 families collected in Hungary, identified by a proband between the age of 7 and 14 who met DSM IV criteria for major depressive disorder or bipolar I/II disorder. There was no evidence for an allelic or genotypic association of three polymorphisms of NTRK2 with COMD in the case-control sample. Also, in the family based sample, using the transmission disequilibrium test (TDT), we did not identify any evidence of allelic association for each marker individually or when haplotypes were analyzed. Based on these results, using these three polymorphisms, we do not find support for NTRK2 as a susceptibility gene for COMD.
authors.affiliation: Department of Psychiatry, Cell and Molecular Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Adams
authors.forename: Karen G
authors.initials: KG
authors.lastname: Wigg
authors.forename: Nicole
authors.initials: N
authors.lastname: King
authors.forename: Irina
authors.initials: I
authors.lastname: Burcescu
authors.forename: Agnes
authors.initials: A
authors.lastname: Vetró
authors.forename: Eniko
authors.initials: E
authors.lastname: Kiss
authors.forename: Ildikó
authors.initials: I
authors.lastname: Baji
authors.forename: Charles J
authors.initials: CJ
authors.lastname: George
authors.forename: James L
authors.initials: JL
authors.lastname: Kennedy
authors.forename: Maria
authors.initials: M
authors.lastname: Kovacs
authors.forename: Cathy L
authors.initials: CL
authors.lastname: Barr
mesh_terms: D017668:Age of Onset; D000483:Alleles; D016022:Case-Control Studies; D002648:Child; D005192:Family Health; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D019964:Mood Disorders / Q000235:genetics*; D009679:Nuclear Family; D011110:Polymorphism, Genetic; D020813:Receptor, trkB / Q000235:genetics*
chemical_list: D020813:Receptor, trkB